Found 0 matching trials
Neoadjuvant Hormone and Radiation Therapy Followed by Radical Prostatectomy in Patients With High-Risk Prostate Cancer
NARATIONALE: Radiation therapy uses high-energy x-rays to damage tumor cells....
Location
National Taiwan University Hospital Yunlin Branch
Androgen-Deprivation Therapy and Radiation Therapy in Treating Patients With Prostate Cancer
PHASE3RATIONALE: Androgens can cause the growth of prostate cancer cells. Androge...
Status
Active Not Recruiting
Location
University of South Alabama Mitchell Cancer Institute
Hypo Fractionated Versus Conventional IMRT in Unfavorable Intermediate- and High-Risk Prostate Cancer
NAThe aim of the study is
1. Statistical evaluation of patients' characteris...
Targeted Radiotherapy for Recurrent Prostate Cancer
NAThe TASTEPRO pilot trial evaluates the feasibility of PSMA PET-CT (Computer...
Location
Tampere University Hospital
A Phase III of Cabazitaxel and Pelvic Radiotherapy in Localized Prostate Cancer and High-risk Features of Relapse
PHASE3The objective of this study is to assess the effect of neoadjuvant cabazita...
Status
Active Not Recruiting
Location
Institut Gustave Roussy
Combined, Intensified and Modulated Adjuvant Therapy in Prostate Carcinoma
NAPatients with high risk prostate cancer may benefit from radiotherapy after...
Location
Multiple Locations
5 Fractions of Pelvic SABR With Intra Prostatic SABR Boost:
NAStereotactic Ablative Body Radiotherapy (SABR) given in 5 weekly fractions....
Location
Sunnybrook Health Sciences Center
Neoadjuvant Chemo-hormonal Therapy Combined With Radical Prostatectomy for Locally Advanced Prostate Cancer
NATo evaluate of the value of radical prostatectomy and extended pelvic lymph...
Location
Multiple Locations
Prostate-cancer Treatment Using Stereotactic Radiotherapy for Oligometastases Ablation in Hormone-sensitive Patients
PHASE3INDICATION: Oligometastatic hormone-sensitive prostate cancer patients. MET...
Status
Active Not Recruiting
Location
Institut Sainte Catherine
A Randomised Controlled Platform Trial Testing Treatments in Metastatic Hormone Sensitive Prostate Cancer
PHASE3STAMPEDE2 is a clinical trial comparing two new treatments with standard of...
Location
Mount Vernon Hospital